The objective of this community-based, non-randomized, quasi-experimental study is to assess the effectiveness of BTL EXILIS technology-based on combined radiofrequency and ultrasound-in women of childbearing age from an industrialized country with a diagnosis of dyspareunia following vaginal delivery.
The primary research question is:
\- Do patients experience a resolution of pain during sexual intercourse after completing the treatment?
The researcher will compare the level of pain during intercourse-following at least one vaginal delivery involving a tear or episiotomy-before and after exposure to the BTL Exilis treatment in the same individual.
Participants:
* Assessment following childbirth with perineal involvement (tear or episiotomy) and presenting with dyspareunia. * Verification of fulfillment of inclusion criteria. * Decision on whether to undergo treatment, following a briefing by the researcher on the process and the signing of the informed consent form for study participation. * Follow-up assessment one and a half months after completing the treatment.
Women of childbearing age
Medical history of at least one prior vaginal delivery
Reported persistent pain during penetrative sexual intercourse
Meeting the clinical criteria for dyspareunia
Contraindications to the study treatment. Women with any medical condition that precludes the use of the study technology
Non-postpartum dyspareunia